Read Larry Connors' blog – Short Term Trading Strategies
-- November 05, 2009 The Hartford (NYSE: HIG | Quote | Chart | News | PowerRating) at $24.03 on a volume of 5.08M shares
In a press release on November 05, The Hartford Launches Voluntary Benefits Solution That Removes Administration Burden For Employers, Workers
Insurer provides a comprehensive system of people, processes and technology that helps employees better understand and manage benefits
SIMSBURY, Conn., Nov 05, 2009 Understanding that employers are being squeezed by increased regulatory pressures, rising costs, and stretched human resources teams, The Hartford Financial Services Group, Inc. (NYSE: HIG | Quote | Chart | News | PowerRating) today unveiled a total voluntary benefits solution for employers with one thousand or more employees.
This new comprehensive system of people, processes and technology for voluntary group life and disability insurance is the result of significant investments by The Hartford, the No. 1 seller of group disability insurance.(1)
About The Hartford
Celebrating nearly 200 years, The Hartford (NYSE: HIG | Quote | Chart | News | PowerRating) is an insurance-based financial services company that serves households, businesses and employees by helping to protect their assets and income from risks, and by managing wealth and retirement needs. A Fortune 500 company, The Hartford is recognized widely for its service expertise and as one of the world's most ethical companies. More information on the company and its financial performance is available atwww.thehartford.com.
-- November 05, 2009 IMS Health (NYSE: RX | Quote | Chart | News | PowerRating) trading at $20.82 on a volume of 24.62M shares
In a press release on November 05, IMS Health to be Acquired by TPG and CPP Investment Board
IMS Shareholders to Receive $22 per Share in Cash; Transaction Valued at $5.2 Billion
NORWALK, Conn., Nov 05, 2009 IMS Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that it has entered into a definitive agreement to be acquired by investment funds managed by TPG Capital ("TPG") and the CPP Investment Board ("CPPIB") in a transaction with a total value of $5.2 billion, including the assumption of debt.
The agreement was unanimously approved by the IMS Board of Directors based upon the recommendation of the Transaction Committee that was established to undertake a review of IMS's strategic alternatives. Under the agreement, IMS shareholders will receive $22.00 cash for each share of IMS common stock they own, representing a premium of approximately 50 percent over the closing share price on Friday, October 16, 2009, the last trading day prior to public speculation that IMS was considering its strategic alternatives.
About IMS
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients' day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide. Additional information is available athttp://www.imshealth.com.
-- November 05, 2009 Duff & Phelps Corporation (NYSE: DUF | Quote | Chart | News | PowerRating) trading at $15.50 on a volume of 639,439 shares.
In a press release out on November 05, Duff & Phelps Announces Pricing of Common Stock Offering
NEW YORK, Nov 05, 2009 Duff & Phelps Corporation (NYSE: DUF), a leading independent financial advisory and investment banking firm, today announced the pricing of a public offering of 2.5 million shares of its Class A common stock at a price of $15.50 per share. Goldman, Sachs & Co. acted as the sole underwriter for the offering.
Duff & Phelps intends to use the net proceeds from this offering to redeem an equal number of units in Duff & Phelps Acquisitions, LLC that are held by existing unit holders.
The offering is being made pursuant to a shelf registration statement filed with the U.S. Securities and Exchange Commission, which became effective on October 26, 2009. Copies of the prospectus supplement and accompanying base prospectus related to this offering may be obtained from Goldman, Sachs & Co., Prospectus Department, 85 Broad Street, New York, NY 10004, telephone: 1-866-471-2526, facsimile: 212-902-9316 or by emailing prospectus-ny@ny.email.gs.com.
About Duff & Phelps
As a leading global independent provider of financial advisory and investment banking services, Duff & Phelps delivers trusted advice to our clients principally in the areas of valuation, transactions, financial restructuring, dispute and taxation. Our world class capabilities and resources, combined with an agile and responsive delivery, distinguish our clients' experience in working with us. With more than 1,200 employees serving clients worldwide through offices in North America, Europe and Asia, Duff & Phelps is committed to fulfilling its mission to protect, recover and maximize value for its clients. Investment banking services in North America are provided by Duff & Phelps Securities, LLC. Investment banking services in Europe are provided by Duff & Phelps Securities Ltd. Duff & Phelps Securities Ltd. is authorized and regulated by the Financial Services Authority. Investment Banking services in France are provided by Duff & Phelps SAS.
-- November 05, 2009 CVS Caremark (NYSE: CVS | Quote | Chart | News | PowerRating) last at $28.72 a volume of 75.76M shares
In a press release out on November 05, David Denton to Become CVS Caremark Chief Financial Officer
Denton replaces David Rickard who retires at year end
WOONSOCKET, R.I., Nov 05, 2009 Laird Daniels named Controller and Chief Accounting Officer CVS Caremark (NYSE: CVS | Quote | Chart | News | PowerRating) today announced the appointment of David M. Denton to the new role of Executive Vice President and Chief Financial Officer, effective January 1, 2010. Denton will succeed David Rickard who announced in February of this year his intention to retire as CFO.
Denton, currently CVS Caremark's SVP, Controller and Chief Accounting Officer, brings nearly twenty years of financial management experience with a focus on the health care and retail drug sectors to his new position. Since joining the company in 1999, he has assumed positions of increasing responsibility including senior finance positions within CVS/pharmacy and CVS Caremark and role of Chief Financial Officer for PharmaCare, a subsidiary of CVS. The selection of Denton as EVP, Chief Financial Officer caps an eight month search that included both internal and external candidates.
About CVS Caremark
CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 7,000 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations section of the Company's Web site, at www.cvscaremark.com/investors, as well as through the press room section of the Company's Web site, at www.cvscaremark.com/newsroom.
-- November 05, 2009 Primus Guaranty, Ltd. (NYSE:PRS) last at $3.36 on a volume of 27,532 shares
In a press release out on November 05, Primus Announces Third Credit Mitigation Transaction
HAMILTON, Bermuda, Nov 05, 2009 Primus Guaranty, Ltd. (NYSE:PRS) announced that its subsidiary, Primus Financial Products, LLC ("Primus Financial") has completed its third credit mitigation transaction. Primus Financial assigned a portfolio of credit swaps with its largest single counterparty, comprising notional principal of $2.65 billion of bespoke tranche transactions and approximately $250 million of single name credit swaps, to a newly formed subsidiary which is wholly owned by Primus Financial. Primus Financial paid its subsidiary an assignment fee of $100 million. The subsidiary and the counterparty have agreed to restructure the portfolio such that the single name credit swaps are terminated and the bespoke tranche transactions are revised to reflect a new notional principal totaling $1.75 billion. In addition, the attachment points on certain of the restructured tranche transactions have been increased. The subsidiary has paid the counterparty a restructuring fee of $10 million. Future credit swap premiums payable by the counterparty on the restructured portfolio are approximately $15 million less than the future premiums on the portfolio prior to restructuring. The last restructured tranche matures in December 2014.
About Primus Guaranty
Primus Guaranty, Ltd. is a Bermuda company with operations in New York, Boston and London. Through its subsidiaries, the company is a leading manager of corporate credit assets and provider of credit protection. Primus manages assets in structured credit funds and operating companies, across a range of asset classes -- including investment grade, high yield and leveraged loans -- using both cash and synthetic instruments.
-- November 05, 2009 Under Armour, (NYSE: UA | Quote | Chart | News | PowerRating) trading at $27.75 on a volume of 124,998 shares
In a press release out on November 05, Under Armour Throws Knock-Out Punch By Signing MMA Champion Georges St-Pierre as a Face of the Top-Selling Athletic Brand
In A Multi-Year Endorsement Deal, St-Pierre Will Be Featured in Under Armour's Upcoming Campaigns Showcasing Fitted ColdGeara(R), Underwear, Recharge(TM) Suit, and New Coreshort product
BALTIMORE, Nov 05, 2009 Under Armour, (NYSE: UA | Quote | Chart | News | PowerRating) the Baltimore-based leader in performance apparel and footwear, announced today it has signed Mixed Martial Arts (MMA) Welterweight Champion Georges St-Pierre to a multi-year endorsement deal. Under the terms of the agreement, St-Pierre, the 2008 Sportsnet Canadian Athlete of the Year, will serve as the face of Under Armour's Underwear, one of the company's most popular items, and will be featured in its multi-platform media campaign beginning this holiday season.
St-Pierre, known by his fans as GSP, will be featured in imagery displayed in Sporting Goods stores across North America, outfitted in Under Armour's ColdGear(R), performance apparel designed to protect athletes in cold temperatures. Beginning in spring 2010, St-Pierre will become the face of Under Armour's long-time top-selling BoxerJock(R) and BoxerBrief Underwear and will serve as one of the primary faces for Under Armour's Recharge(TM) suit, a suit designed to re-energize your body, promote muscle repair and reduce swelling following a workout.
About Under Armour, Inc.
Under Armour (NYSE: UA | Quote | Chart | News | PowerRating) is a leading developer, marketer, and distributor of branded performance apparel, footwear, and accessories. The brand's moisture-wicking synthetic fabrications are engineered in many different designs and styles for wear in nearly every climate to provide a performance alternative to traditional natural fiber products. The Company's products are sold worldwide and worn by athletes at all levels, from youth to professional, on playing fields around the globe. The Under Armour global headquarters is in Baltimore, Maryland, with European headquarters in Amsterdam's Olympic Stadium, and additional offices in Denver, Hong Kong, Toronto, and Guangzhou, China. For further information, please visit the Company's website at www.underarmour.com.
www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com
www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
CONTACT: PicksThatMove.com e-mail: Info@picksthatmove.com WWW: http://www.picksthatmove.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
